Abdelhak, A., Huss, A., Kassubek, J., Tumani, H., & Otto, M. (2018). Serum GFAP as a biomarker for disease severity in multiple sclerosis. Scientific reports, 8(1), 14798-7. https://doi.org/10.1038/s41598-018-33158-8
Chicago Style (17th ed.) CitationAbdelhak, A., A. Huss, J. Kassubek, H. Tumani, and M. Otto. "Serum GFAP as a Biomarker for Disease Severity in Multiple Sclerosis." Scientific Reports 8, no. 1 (2018): 14798-7. https://doi.org/10.1038/s41598-018-33158-8.
MLA (9th ed.) CitationAbdelhak, A., et al. "Serum GFAP as a Biomarker for Disease Severity in Multiple Sclerosis." Scientific Reports, vol. 8, no. 1, 2018, pp. 14798-7, https://doi.org/10.1038/s41598-018-33158-8.
Warning: These citations may not always be 100% accurate.